Docket

33874

Her Majesty the Queen v. GlaxoSmithKline Inc.

(Federal Court) (Civil) (By Leave)

(Sealing order)

Proceedings
Date Proceeding Filed By
(if applicable)
2013-11-07 Appeal closed
2013-11-07 Certificate of taxation issued to, Patricia J. Wilson
2013-11-07 Decision on bill of costs, (the amount claimed by Her Majesty the Queen was offset in the amount allowed to GlaxoSmithKline Inc.), in the amount of $10,842.11, DeRg
2013-11-07 Submission of bill of costs, (both bills of costs), DeRg
2013-11-07 Order on motion to extend time, (by the DEPUTY REGISTRAR)
2013-11-07 Decision on motion to extend time, to serve and file its notice of taxation and bill of costs to May 14, 2013, DeRg, UPON APPLICATION on behalf of the appellant/respondent on cross-appeal for an order extending the time within which to serve and file its notice of taxation and bill of costs to May 14, 2013;
AND THE MATERIAL FILED having been read;
IT IS HEREBY ORDERED THAT:
The motion is granted.
Granted
2013-11-07 Submission of motion to extend time, DeRg
2013-06-03 Response to motion to extend time, (Letter Form), from Sharon Ford by fax, re: does not oppose the motion for extension of time, Completed on: 2013-06-03 GlaxoSmithKline Inc.
2013-05-24 Motion to extend time, (Letter Form), to file a notice of taxation and bill of costs, Completed on: 2013-05-24 Her Majesty the Queen
2013-05-21 Reply to bill of costs, (filed by GlaxoSmithKline Inc.), Completed on: 2013-05-21 GlaxoSmithKline Inc.
2013-05-14 Bill of costs, on the cross-appeal and on the application for leave to cross-appeal (included in the response to the bill of costs filed by GlaxoSmithKline Inc.) (motion for extension of time filed on May 24/13), Completed on: 2013-05-14 Her Majesty the Queen
2013-05-14 Response to bill of costs, (notice of taxation and bill of costs on the cross-appeal and application for leave to cross-appeal included in the response), Completed on: 2013-05-14 Her Majesty the Queen
2013-05-10 Record returned to the Registrar of the Court of Appeal, 2 boxes
2013-05-06 Bill of costs, (Book Form), Completed on: 2013-05-06 GlaxoSmithKline Inc.
2012-10-19 Formal judgment sent to the registrar of the court of appeal and all parties
2012-10-19 Judgment on appeal and notice of deposit of judgment sent to all parties
2012-10-18 Judgment on the appeal rendered, CJ De Abe Ro Cro Mo Ka, The appeal from the judgment of the Federal Court of Appeal, Number A-345-08, 2010 FCA 201, dated July 26, 2010, heard on January 13, 2012, is dismissed with costs throughout. The cross-appeal is dismissed with costs in this Court. The matter is remitted to the Tax Court for redetermination.
Dismissed, costs in this Court and courts below
2012-05-24 Appeal court record, 2 boxes
2012-01-31 Transcription received, (65 pages)
2012-01-13 Judgment reserved OR rendered with reasons to follow
2012-01-13 Hearing of the appeal, 2012-01-13, CJ De Abe Ro Cro Mo Ka
Judgment reserved
2012-01-13 General proceeding, Form re: Webcast Her Majesty the Queen
2012-01-13 Acknowledgement and consent for video taping of proceedings, All parties consented
2012-01-13 Respondent's condensed book, Rec'd in Court GlaxoSmithKline Inc.
2012-01-13 Appellant's condensed book, rec'd in Court Her Majesty the Queen
2012-01-12 Correspondence received from, Patricia Wilson rec'd by e-mail re: request live webcasting GlaxoSmithKline Inc.
2012-01-04 Correspondence received from, Mr. Noble re: Supplemental Authorities and consent (sent to the judges Jan. 6/12) GlaxoSmithKline Inc.
2012-01-04 Supplemental document, (Authorities) (sent to the judges Jan. 6/12), Completed on: 2012-01-04 Her Majesty the Queen
2011-12-22 Supplemental document, Supplementary record, Completed on: 2011-12-22 GlaxoSmithKline Inc.
2011-12-22 Correspondence received from, Wendy Burnham by fax, re.: request for reserved seats at the hearing Her Majesty the Queen
2011-12-22 Notice of appearance, Wendy Burnham, Eric Noble and Karen Janke will be present at the hearing. Her Majesty the Queen
2011-12-20 Notice of appearance, Al Meghji, Joseph M. Steiner, Amanda Heale and Pooja Samtani will be appearing GlaxoSmithKline Inc.
2011-12-20 Correspondence received from, Osler by fax, re.: request for reserved seats at the hearing GlaxoSmithKline Inc.
2011-12-08 Notice of hearing sent to parties
2011-12-07 Appeal hearing scheduled, 2012-01-13
Judgment reserved
2011-10-25 Order on motion to seal, (BY THE REGISTRAR)
2011-10-25 Decision on motion to seal, Reg, UPON APPLICATION by counsel on behalf of the respondent for an order sealing the unredacted version of the respondent's factum;
AND HAVING READ the material filed;
IT IS HEREBY ORDERED THAT:
1) The motion is granted.
2) The sealed unredacted version of the respondent's factum will only be made available to counsel for the appellant, counsel for the respondent in this Court and the Courts below, Ottawa agents, members of this Court, Court staff and other persons as the parties may, in writing, agree or as this Court may further order
Granted
2011-10-25 Submission of motion to seal, Reg
2011-09-20 Appeal perfected for hearing
2011-09-13 Correspondence received from, (Letter Form), from P. Olsen, dated September 13, 2011 re: sealing orders from the Tax Court GlaxoSmithKline Inc.
2011-09-13 Appellant's book of authorities - cross appeal, Included in Respondent's Authorities, Completed on: 2011-09-13 GlaxoSmithKline Inc.
2011-09-13 Appellant's record - cross appeal, Included in Respondent's Record GlaxoSmithKline Inc.
2011-09-13 Appellant's factum - cross appeal, Included in respondent's factum, Completed on: 2011-09-13 GlaxoSmithKline Inc.
2011-09-13 Respondent's record, (Vol. 1 to 3, volume 3 is SEALED), Completed on: 2011-09-13 GlaxoSmithKline Inc.
2011-09-13 Respondent's book of authorities, (Vol. 1 and 3), Completed on: 2011-09-13 GlaxoSmithKline Inc.
2011-09-13 Respondent's factum, (SEALED + 2 redacted version) - Motion to seal rec'd Sept. 13/11 - cross-appeal included, Completed on: 2011-09-13 GlaxoSmithKline Inc.
2011-09-13 Motion to seal, Bookform, Completed on: 2011-09-13 GlaxoSmithKline Inc.
2011-07-28 Order on motion to seal, (BY THE REGISTRAR)
2011-07-28 Decision on motion to seal, Reg, UPON APPLICATION by counsel on behalf of the appellant for an order sealing the unredacted version of the appellant's factum;
AND HAVING READ the material filed;
IT IS HEREBY ORDERED THAT:
1) The motion is granted.
2) The sealed unredacted version of the appellant's factum will only be made available to counsel for the appellant, counsel for the respondent, Ottawa agents, members of this Court, Court staff and other persons as the parties may, in writing, agree or as this Court may further order
Granted
2011-07-28 Submission of motion to seal, Reg
2011-07-25 Response to motion to seal, (Letter Form), from Patricia J. Wilson dated July 25/11, Completed on: 2011-07-25 GlaxoSmithKline Inc.
2011-07-21 Letter advising the parties of tentative hearing date and filing deadlines (Leave granted)
2011-07-19 Appellant's book of authorities, Completed on: 2011-07-19 Her Majesty the Queen
2011-07-19 Appellant's record, Volumes VII & VIII are SEALED (8 volumes), Completed on: 2011-07-19 Her Majesty the Queen
2011-07-19 Appellant's factum, SEALED (3 redacted copies filed), Completed on: 2011-07-19 Her Majesty the Queen
2011-07-19 Motion to seal, the unredacted version of the appellant's factum, Completed on: 2011-07-19 Her Majesty the Queen
2011-04-26 Notice of appeal, Completed on: 2011-04-26 Her Majesty the Queen
2011-03-25 Copy of formal judgment sent to Registrar of the Court of Appeal and all parties
2011-03-25 Judgment on leave sent to the parties
2011-03-24 Decision on the application for leave to appeal, Bi F Ro, The applications for leave to appeal and for leave to cross-appeal from the judgment of the Federal Court of Appeal, Number A-345-08, 2010 FCA 201, dated July 26, 2010, are granted with costs in the cause. Each party shall be restricted to one factum of 40 pages to address both the appeal and the cross-appeal.
Granted, with costs in the cause
2011-03-24 Decision on the application for leave to cross-appeal, Bi F Ro
Granted, with costs in the cause
2010-12-06 All materials on application for leave submitted to the Judges, Bi F Ro
2010-12-06 All material on the application for leave to cross-appeal submitted to the Judges, Bi F Ro
2010-11-26 Reply to the memorandum in response to the argument on cross-appeal, Completed on: 2010-11-26 GlaxoSmithKline Inc.
2010-11-19 Memorandum of argument in response to the cross-appeal, Completed on: 2010-11-19 Her Majesty the Queen
2010-11-01 Applicant's reply to respondent's argument, Completed on: 2010-11-01 Her Majesty the Queen
2010-10-22 Application for leave to cross-appeal, Included in the response, Completed on: 2010-10-22 GlaxoSmithKline Inc.
2010-10-22 Respondent's response on the application for leave to appeal, Completed on: 2010-10-22 GlaxoSmithKline Inc.
2010-09-29 Letter acknowledging receipt of a complete application for leave to appeal
2010-09-29 Application for leave to appeal, (4 volumes), Completed on: 2010-09-29 Her Majesty the Queen